drugset / Trial / NCT00024544

Pilot Study in Patients With Symptomatic Steroid-Naive Asthma

NCT00024544 ↗

Phase 2 Completed 120 enrolled Facet Biotech
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate an investigational medication to treat chronic asthma. The research is being conducted at 20 clinical research sites in the US and is open to both men and women ages 18 to 70 years. Participants in the study will have a number of visits to a research site over an 8-month period. All study-related care and medication is provided to qualified participants at no cost. This includes all visits, examinations and laboratory work.

Timeline

Start
2001-08
Primary completion
2003-02
Completion
2003-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Pascolizumab Monoclonal antibody — —

Indications